Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Acta Physiol (Oxf). 2011 Apr 22;203(1):139–147. doi: 10.1111/j.1748-1716.2011.02285.x

Fig. 6.

Fig. 6

Immunohistochemistry staining (a) and Western blot analysis (b) showing tyrosine hydroxylase (TH) expression in mesenteric arteries of rats 3 days after control or TRPV1 shRNA treatment. The left and right panels indicate representative Western blots and quantification results (% β-actin arbitrary units), respectively. Values are mean ± SE (n = 5). *P<0.05 compared with control shRNA-treated group. Scale bars, 100 μm.